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Abstract
Background: Previously we generated a chronic obstructive pulmonary disease (COPD) specific knowledge base
(http://www.copdknowledgebase.eu) from clinical and experimental data, text-mining results and public databases.
This knowledge base allowed the retrieval of specific molecular networks together with integrated clinical and
experimental data.
Results: The COPDKB has now been extended to integrate over 40 public data sources on functional interaction
(e.g. signal transduction, transcriptional regulation, protein-protein interaction, gene-disease association). In addition
we integrated COPD-specific expression and co-morbidity networks connecting over 6 000 genes/proteins with
physiological parameters and disease states. Three mathematical models describing different aspects of systemic
effects of COPD were connected to clinical and experimental data. We have completely redesigned the technical
architecture of the user interface and now provide html and web browser-based access and form-based searches.
A network search enables the use of interconnecting information and the generation of disease-specific sub-
networks from general knowledge. Integration with the Synergy-COPD Simulation Environment enables multi-scale
integrated simulation of individual computational models while integration with a Clinical Decision Support System
allows delivery into clinical practice.
Conclusions: The COPD Knowledge Base is the only publicly available knowledge resource dedicated to COPD
and combining genetic information with molecular, physiological and clinical data as well as mathematical
modelling. Its integrated analysis functions provide overviews about clinical trends and connections while its
semantically mapped content enables complex analysis approaches. We plan to further extend the COPDKB by
offering it as a repository to publish and semantically integrate data from relevant clinical trials. The COPDKB is
freely available after registration at http://www.copdknowledgebase.eu.
Background
We previously reported the public availability of a chronic
obstructive pulmonary disease (COPD) specific knowledge
base [1]. This COPDKB semantically integrated existing
COPD related knowledge such as genotype - phenotype
relations or signal transduction pathways into structured
networks that were connected with clinical and experi-
mental data. To this end an object-oriented knowledge
model was generated which contained concepts such as
“gene”, “disease” or “organ” and their associations such as
“causes”, “damages”. We established a general human
molecular knowledge network of over 3.6 million connec-
tions (e.g. gene-disease associations, protein-protein inter-
actions) with disease-specific signal transduction (54
pathways) and metabolite (122) information manually
curated from the literature. Initial search, retrieval and R-
plugin -based data-mining methods integrated into the
COPDKB enabled the retrieval of disease- or case-specific
sub-networks e.g. lung specific by expert users for data
analysis and model generation. To this end a thick Java cli-
ent provided a wizard based user interface to create nat-
ural language like queries such as
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“Object to find is a Patient which simultaneously is
annotated by Patient diagnostic data which has GOLD
attribute greater than 2 and is annotated by Patient
Anthropometrics which has BMI-BT attribute less than
18 and never is diagnosed with a NCI Thesaurus entry
which is inferred by ontology entry which has name like
‘*cancer*’”, which would retrieve all patients diagnosed
with COPD severity grade above 2 but no cancer which
have low body mass index. In addition graph based
navigation allowed single step network expansions to e.
g. navigate from a group of patients to the diseases they
are diagnosed with and from there to the genes asso-
ciated with these diseases. However, validation with user
groups showed that to enable application by clinical
researchers, a significant simplification of the user inter-
face was required.
To extend the applicability of the COPDKB as a cen-
tral part of a biomedical research platform (see [2]) we
identified several aims:
1. Update existing and integrate further COPD-specific
knowledge and semantically map it to clinical, physio-
logical and molecular data of COPD patients to gener-
ate a full repository of COPD-associated features.
2. Extend the capability of knowledge representation
to include non-SBML-based mathematical models and
integrate COPD-specific computational models.
Semantically connect models of different types (e.g.
ODE, probabilistic) with each other as well as existing
relevant data.
3. Generate an intuitive browser-based user interface
for clinical and biomedical researchers.
4. Connect the aggregated COPD-specific knowledge
to a clinical decision support system (CDSS), which
provides translation into clinical practice.
Methods
The requirement specification used elicitation methods
such as user observations, focus groups, interviews and
workshops to establish the use cases and workflows, which
were refined based on a prototyping approach applying
agile development methods. The architecture design
approach followed the ISO/IEC 42010:2007 standard.
Implementation of the user interface framework is based
on the open source Foswiki framework (http://www.fos-
wiki.org) for which a plugin was developed to connect the
BioXM™ Knowledge Management Environment. While
details of the technical architecture of BioXM have been
reported elsewhere [3] we briefly summarise it here to aid
understanding. As depicted in Figure 1 BioXM is imple-
mented as a platform-independent Java client-server appli-
cation with modular architecture and a relational database
management system backend. The Foswiki plugin calls a
dedicated servlet deployed in an Apache Tomcat servlet
container. The servlet connects to different BioXM appli-
cation server programming interfaces (APIs) to execute
searches and retrieve pre-defined reports through the wiki
plugin into an html user interface which is accessible by
any modern web-browser. A BioXM SOAP web service is
used to interoperate with external applications such as the
Clinical Decision Support System (CDSS) and Simulation
Environment (SE). Data analyses methods are based on R
scripts, which the BioXM R-plugin calls and presents the
results directly in the user interface. Based on this plugin,
content displayed in the browser can be dynamically gen-
erated from the knowledge base repository. The resulting
user interface was iteratively validated and refined by focus
groups of biomedical researchers within the Synergy-
COPD projects as well as biohealth research students
during two subsequent summer schools of the Erasmus
Mundus BioHealth Computing program (see [4] ).
Figure 1 BioXM module structure. The modular BioXM architecture decouples tasks such as authorisation and access control from data
management, search and reporting. The dynamic semantic knowledge model defines which objects and associations can be represented and
analysed. Selecting from multiple “App” functions a highly specific browser-based user interface can be generated within the Foswiki open
source framework.
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Data integration and semantic mapping was performed
as described previously [1]. Briefly summarized, semantic
mapping templates are generated manually between the
conceptual data model of individual resources and the
disease-specific knowledge model. Integration of data
updates are subsequently performed automatically.
Manual curation of disease-specific knowledge was gen-
erated by extracting from expert-specified publications
and the results were enriched by expert panel discussions.
Results
Overview of the knowledge base
The COPDKB now provides interoperability and integra-
tion between multiple data sources and tools commonly
used in biomedical research. It also extends to include
new tools such as a multi-scale Simulation Environment
[5] that enables the execution of disease-specific simula-
tions based on the integration of multiple sub-models.
The COPDKB is based on the concept of “knowledge as
network” and bridges multiple sources and scales of
knowledge by abstracting commonly used concepts to
communicate disease-specific knowledge into objects and
their relations. Structuring explicit and implicit knowledge
into these formal concepts enables the use of existing,
well-defined vocabularies (e.g. GO[6], ICD10 [7]) and
standards (e.g. SBML[8], HL7[9]) to represent molecular,
biochemical and clinical processes.
One of the challenges for the use of computation models
in biomedical research is the integration of models at dif-
ferent scales as well as the mapping to corresponding clin-
ical, physiological or molecular data. We defined standard
operating procedures for model documentation and devel-
oped a realisation for the concept of composite use of
orthogonal ontologies [10] to create semantic descriptions
for models, model parameters and clinical parameters.
The concept of combinatorial ontology use. Traditionally,
ontologies are created with the intention to establish well
defined, highly detailed concepts that capture the full
semantic meaning of complex facts such as “positive regu-
lation by symbiont of defense-related host calcium-depen-
dent protein kinase pathway (GO:0052102)”. In this way
such a fact can be expressed by assigning a single ontologi-
cal term. However, due to the complexity and expressivity
of descriptions for biomedical functions and processes
especially in physiology often no single ontological con-
cept will fully describe the semantic meaning. Therefore a
combinatorial description which combines multiple con-
cepts has to be created semi-automatically e.g. by match-
ing a free text description such as “partial arterial blood
pressure” to terms in existing ontologies and then select-
ing the appropriate concepts from several, ideally orthogo-
nal i.e. non-overlapping, ontologies, to generate an overall
complete representation such as “MESH:D010313 Partial
Pressure; PubChem:977 Oxygen; FMA:83066 Portion of
arterial blood”. Our realisation of this concept included
standards for the definition of spatio-temporal compart-
ments to allow ontology-based model-model and model-
data connection. As a rule concepts should be selected
from within a single ontology but if this does not create a
full semantic description concepts from different ontolo-
gies can be combined. New inference methods are
required to make use of such combinatorial descriptions
and we decided to implement a network similarity search
approach, which treats individual descriptors as objects in
a network and uses within-ontology as well as between-
ontology relations to infer object equivalence. Specifically,
our algorithm treats the collection of descriptors as a speci-
fic network (semantic_descriptorA) and searches all other
existing descriptor collections (semantic_descriptorX to
semantic_descriptorY) for “similar” networks. A semantic_
descriptor is more similar to the input the more a) shared
nodes (ontology entries); b) identical edges (connections
between two ontology entries); c) similar nodes (ontology
entries connected to the identical node by intra- and inter-
ontology relationship, i.e., ontological inference) and d)
similar edges (alternative edge classes connecting identical
or similar nodes) are found. A similarity score is calculated
by summing individual node/edge scores multiplied by the
coverage, i.e., total score = Sum(individual scores) * cover-
age. Individual scores are defined as “1” for identical
matches and scores for similar nodes/edges are derived by
dividing 1 by the number of required steps to reach the
“similar” object, i.e., a distance-based measure with dimin-
ishing contribution. The coverage is calculated as a fraction
of objects in the input semantic_descriptor actually recov-
ered in the search targets.
It is therefore possible to deduce, for example, a 98%
similarity between the above described model parameter
and a clinical parameter described as “NCI: C25378
Partial; NCI: C25195 Pressure; PubChem:977 Oxygen;
FMA:45623 Systemic arterial system” (see Figure 2). The
proposed mappings are verified manually and, if found
true, are fixed, enabling the parameterisation of computa-
tional models based on personalised data, the integrative
simulation of multi-scale models and the subsequent vali-
dation of model predictions against individual clinical data.
In addition to the semantic description of different types
of knowledge and data, we therefore generated a technical
integration between the three compounds required for
integrative simulation and clinical decision support, the
COPDKB, the Simulation Environment (SE, [5]) and Clini-
cal Decision Support System (CDSS, [11]). We generated
an architecture meta-model consisting of the following
concepts: software components, graphical user interface
(GUI), application programming interface (API), data
types and information flow. Figure 3 shows an integrative
UML-type diagram of the organisational, infrastructural
and informational architecture views depicting the
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involved software components, their APIs and the infor-
mation flows between them.
The user interaction was designed within the indivi-
dual software applications to optimise the use-case and
user-group-dependent issues. Therefore the COPDKB
provides the primary access point to integrate, curate,
search and retrieve COPD-related knowledge; the SE
interface is designed to enable the explorative execution
and personalisation of integrated, COPD-related compu-
tational models; and the CDSS ideally becomes unobtru-
sively integrated into the user interfaces of existing
clinical information and management systems to extend
the functionality of accepted clinical practice user inter-
faces to provide disease-specific, individualised support.
Resources added to the COPDKB
We extended the disease-specific structured knowledge
network significantly with several new resources (see
Table 1 for an overview). Criteria for inclusion of new
resources were the major aims of the Synergy-COPD
project (see [2]): a) to analyse systemic, especially skele-
tal muscle related mechanisms involved in COPD b) to
analyse co-morbidity related COPD heterogeneity and
corresponding molecular mechanisms and finally c) to
aid the generation of clinical decision support for diag-
nosis and therapy. To this end we applied literature
mining, integration of existing structured databases,
clinical studies and ontologies as follows:
1) Additional COPD-associated knowledge was
curated from the literature. Within the Synergy-COPD
project a main focus was on the understanding for epi-
genetic regulation of muscle phenotypes and develop-
ment [12] as well as disease co-morbidities derived
from OMIM gene-disease associations [13] and patient
records [14].
Figure 2 Semantic network similarity. “Equivalent” meaning of different parameters is determined by the overlap of their corresponding
semantic descriptors, taking into account transitive relations within and between ontologies.
Figure 3 Software architecture. Integrative UML-like diagram
representing the organisational, infrastructural and informational view
of the software architecture. All modules communicate based on
WebServices. The COPDKB provides information of type model, model
paramters, parameter values (summarised as “simulation knowledge”)
and experimental data to the SE. The SE feeds back simulation results.
With the CDSS the COPDKB exchanges requests for information on
knowledge about co-morbidities and drug-interactions and provides
corresponding search results. COPDKB = COPD Knowledge Base, SE =
Simulation Environment, CDSS = Clinical Decision Support System, API
= Application Programming Interface.
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2) The general knowledge on human regulatory pro-
cesses was extended by integration of miRNA regula-
tion information from miRBase [15] and transcriptional
regulation information from ITFP [16].
3) Regarding clinical COPD data, we integrated a
second major study on COPD, PAC-COPD [17],
which focuses on the phenotypic heterogeneity and
the extent to which this heterogeneity is related to
clinical development of COPD.
4) We extended the range of ontologies integrated into
the COPDKB to improve the coverage of medical
terms, diagnosis and processes. To this end we inte-
grated the Medical Subject Headings (MeSH, [18]), the
International Classification of Diseases with Clinical
Modifications, Ninth and Tenth Revision (ICD9-CM,
ICD-10-CM) [19] and SNOMED [20]. We used the
UMLS Metathesaurus [21] to derive mappings between
the different medical vocabularies and managed to
relate over 150 000 concepts. These mappings allowed
us to integrate a number of different gene-disease asso-
ciation resources which had used different disease
vocabularies e.g. OMIM or ICD9.
5) Finally the COPDKB was extended significantly by
results derived from the Synergy-COPD project.
We updated the expression-based association network
derived from the BioBridge clinical study [22] with a new
version now integrating gene expression data with physio-
logical attributes such as VO2max, protein modifications
and metabolite measurements providing a COPD-train-
ing-specific network. A further three gene-expression-
based association networks specific to angiogenesis in
young and elderly adults as well as a mouse model on
inactivity effects on muscle were made available (personal
communication FF).
In addition to the general co-morbidity network men-
tioned above, two COPD-specific co-morbidity networks
were generated within the project based on US Medicare
and Swedish health system patient records totalling
13 million patients over 3 years [14] and 5 million patients
over 9 years (personal communication DGC), respectively.
To normalise health-system-specific differences in disease
coding, a disease grouping was developed by clinical
experts and integrated into the COPDKB. Similar to the
disease grouping, we needed to bridge and unify signal
transduction pathway, transcriptional regulation and
metabolism information integrated from databases such as
KEGG [23] and Reactome [24] as well as from COPD-spe-
cific literature mining efforts reported earlier [1]. To this
end we generated a Jaccards index-based clustering based
on the overlap of pathway participants. At a conservative
cut off of 0% FDR, this resulted in 13 groups summarising
421 individual pathways (out of 1367 total). Finally, we
integrated computational models describing different cells,
Table 1 Additional resources integrated into the COPDKB.




BioBridge 8w training extended by protein and metabolite measurements 4878 11448
Co-morbidity network Co-morbidity network from OMIM gene-disease associations as well as
Medicare and Swedish health system patient data
8 435 3 973 126
COPD literature mining GWAS and epigenetic gene- disease associations 18 20
Disease grouping Expert-based manual grouping of diseases 493 diseases 27 groups
Human angiogenesis
young, old
Public, angiogenesis-related expression data 3691 3782
ICD 9 International classification of disease, ninth revision 13 222
ICD 10 International classification of disease, tenth revision 12 416
ITFP Transcription factors and targets 2 143 TF, 6 710
targets
74 907
MeSH Medical subject headings 24 767
miRbase micro RNA 2024 human miRNA
miRTarBase microRNA targets 12 194 human targets 38 311
Mouse inactivity-induced
muscle wasting
Public mouse, inactivity-induced muscle wasting data gene expression
GSE25908,
15 287 154 597
PAC-COPD Clinical study 342 patients, 260
clinical attributes
Pathway network Jaccard index based clustering of pathways from KEGG, Reactome and the
BioBridge COPD text mining
1138 pathways 1815
associations
SNOMED-CT Systematized Nomenclature of Medicine – Clinical Terms 296 519
Data sources added since the first release of the COPDKB
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tissues, organs and physiological processes involved in
COPD and its systemic effects. Three of these form the
core of a COPD disease model, specifically a lung air and
blood flow model [25] an oxygen transport model [26-28]
and a muscle cell bioenergetics and ROS production
model [29,30].
Overall the COPDKB now provides access to almost 850
000 nodes, from genes, proteins and metabolites to cells,
tissues and organs. 9.5 million associations between these
nodes can be mined to derive COPD-specific hypotheses
and data.
Tools for mining
The simplest way to work with the updated COPDKB is
by accessing its new, HyperText Markup Language
(HTML) and browser-based user interface (see Additional
file 1 for a detailed description and screenshots). It pro-
vides individual sections for disease-specific public knowl-
edge, analysis results, mathematical and network models,
as well as clinical data.
The browsing functions in each of these sections allow
users to navigate through specific sub-sections e.g. the
list of all COPD-associated genes or pathways.
All integrated information can be exported and can be
filtered by keyword or numerical value using the column
selector (e.g. “gene function: DNA binding” or “expression
value: >1 AND < 100”). Cross-navigation between seman-
tically mapped or associated data types is possible by fol-
lowing the “Change type” buttons, for example, to jump
from a list of genes to the diseases associated with them.
The “Data matrix” button allows users to show actual data
associated to any displayed entity (if the user has access
to those data, see above). On such a data matrix the
“Statistics” button allows access to a simple box-plot
overview statistic (mean, STDEV, min, max, quartiles) as
well as t-test-based comparison of two groups (e.g. FEV1
for high/low BMI COPD patients).
In addition to the simple browse and filter access, we
implemented a set of form-based searches, which allow
more direct access to information and are continuously
expanded based on user feedback. Currently the search
form for patient selection is based on all clinical parameters
such as BMI or dyspnoea Borg scale, allowing minimum
and maximum threshold values to be set (Figure 4). Other
search forms allow molecular data (e.g. metabolite or pro-
tein measurements) to be retrieved.
Two interactive data-mining methods, the network
search and network ranking, are currently available only
from the Java-based expert user interface. These expert-
generated results are then made available in the standard
user interface in the same way as other data. The network
search is a variant of the breadth-first-search [31], a graph
search algorithm that begins at the root node and explores
all the neighbouring nodes, which is iteratively repeated
for each neighbour until a target node is reached. Within
the COPDKB the path between nodes (the “associations”)
receives user-defined penalty scores and only the alterna-
tive with the lowest score or all alternatives below a cer-
tain threshold are retained. Different association types can
carry different penalty scores. For example, a “high quality”
protein-protein interaction (PPI) derived from co-immu-
noprecipitation might carry a penalty score of 1 while a
“low quality” PPI detected by two-hybrid experiments
might have a score of 3. Based on the overall penalty
score, shorter and more “high quality” paths are preferred.
The network ranking method developed within Synergy-
COPD takes the result of a network search and assigns
additional quality values to each of the nodes; these quality
Figure 4 Search form. Search forms provide pre-defined selections of parameters for which thresholds can be set to retrieve data. Here the
body mass index was selected to retrieve patients with corresponding values.
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values can represent complex information such as “num-
ber of associated diseases” or “variability in muscle expres-
sion”, the later derived from the analysis of over 4000
muscle-specific expression data sets available in GEO [32].
Finally the “network similarity” search is available
directly from the standard COPDKB user interface. It
compares different networks, e.g. signal transduction
pathways or semantic descriptors of model parameters,
based on the occurrence of identical or “similar” nodes
and associations. In this context similarity is defined as
proximity within an ontology. Based on this search
method, a list of clinical and model parameters, for
example, can be ranked according to their semantic
similarity.
Major uses in Synergy-COPD
So far the major use for the COPDKB has been as the
central collaboration and biomedical research platform
within the Synergy-COPD project. As Systems Medicine
is an inherently interdisciplinary process, it is extremely
important to enable the generation of a common lan-
guage between experts from different disciplines. The
COPDKB has been used to map between knowledge and
data from clinical researchers, computer scientists and
mathematicians using the semantic description concept
and the network similarity search. Clinical parameters
from two different clinical studies have been unified and
integrated with three computational models and eight
association networks. While the COPDKB currently pro-
vides only simple analysis features it has been extensively
used to support complex analysis workflows. Integrative
network association analysis on combined clinical and
molecular (expression, metabolic, protein) data was
enabled by the corresponding data mapping and integra-
tion in the COPDKB [22]. The connection between data
analysis results and the existing computational models
was derived from network searches which took the highly
ranked genes/proteins/metabolites/clinical parameters
from the data analysis and searched for connecting paths
to the described model parameters based on, in case of
the bioenergetics model [29,30], mappings to reference
genes/proteins/metabolites. Another important type of
information provided by the COPDKB were the multiple
mapped and integrated gene-disease and gene-gene asso-
ciations. These were mainly used to provide molecular
connections and mechanisms between different diseases
derived, for example, from co-morbidity analysis. As
described separately [33], the COPDKB also forms the
knowledge backbone for the Simulation Environment. It
provides the mappings between different models that are
required by the SE for integrative multi-scale model
execution and it subsequently holds the simulation
results and maps them back to corresponding clinical
data for validation. The final major use case for the
COPDKB is to act as a fact repository for the Clinical
Decision Support System (CDSS, [11]). The COPDKB
provides co-morbidity and drug-drug interaction infor-
mation to the CDSS, which subsequently generates alerts
on possible disease co-occurrences or adverse drug
interactions.
A final important use case turned out to be using the
COPDKB as an educational tool to introduce non-clini-
cians to the issues and challenges of COPD-related Systems
Medicine. Within the Erasmus Mundus BioHealth Com-
puting program [4] the COPDKB was the initial access
point for all students to learn about the different aspects of
Systems Medicine, from clinical question to available
knowledge and data, to analysis methods and predictive
mathematical models. The feedback provided by these
focus groups in turn greatly helped to improve the
COPDKB user interface and shape further requirements.
Discussion
Within biomedical research we increasingly rely on com-
putational support to keep track of our understanding of
complex systems such as ecosystems or the human body
and its malfunctions. So far, within Systems Medicine
only a few examples of computational disease knowledge
resources are available (e.g. [34]) and the COPDKB is to
our knowledge the only such resource regarding COPD.
Moreover, by integrating the COPDKB tightly with a
Simulation Environment, it extends from a dynamic, but
still lexicon-type reference resource, into a truly predic-
tive and individual tool. Due to the integration with a
Clinical Decision Support System it is able to deliver
these individualised predictions directly into clinical
practice.
However, several caveats remain. Although many of
the available relevant structured public knowledge
resources have been integrated, the majority of disease
knowledge still remains hidden in the literature. Text-
mining methods and manual curation provide some
inroads into this wealth, but are far from sufficient to
generate a truly complete picture of our current knowl-
edge. Another limitation is the quality and context spe-
cificity of the integrated knowledge. Many resources do
not extract these measures and therefore they remain
hidden in the original literature. Detailed knowledge
structuring efforts, such as developing a mathematical
model of a certain process, still require major manual
literature-review efforts; the COPDKB only provides a
rough framework and an indication where to start and
which pathways to follow.
Regarding a full biomedical research platform, the
COPDKB currently still lacks accessibility of the integrated
data-analysis and data-mining methods for non-expert
users. The majority of available knowledge is on the mole-
cular level and only a small part of it is specific to COPD.
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Conclusions
The COPDKB provides a step in our development of a
biomedical research platform for System Medicine as
well as the most comprehensive COPD-specific knowl-
edge base. The COPDKB proved a valuable tool for the
analysis and computational modelling of COPD
although several gaps and weaknesses still remain, some
inherent to the platform itself, some generic from the
way we still communicate knowledge. Future develop-
ments will focus on three aspects: improving the quality
of the disease-specific knowledge, extending the inte-
grated COPD-related clinical data sources and bringing
the validated data analysis workflows into the reach of
non-bioinformaticians.
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